Grace Therapeutics
GRCE
#9703
Rank
A$79.74 M
Marketcap
A$5.15
Share price
1.10%
Change (1 day)
-7.92%
Change (1 year)

Earnings for Grace Therapeutics (GRCE)

Earnings in 2025 (TTM): -A$14.8 Million

According to Grace Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$23.09 Million, an increase over its 2023 earnings that were of -A$68.23 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Grace Therapeutics from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$14.8 Million-35.91%
2024 -A$23.09 Million-66.16%
2023 -A$68.23 Million161.72%
2022 -A$26.07 Million60.58%
2021 -A$16.24 Million-462.11%
2020 A$4.48 M
2018 -A$35.32 Million
2015 -A$5.73 Million
2013 -A$13.93 Million49.55%
2012 -A$9.32 Million